17:33 ETRegeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Lossesprnewswire·4 hours agoREGN+1.70%
14:43 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Forte Biosciences, Inc. (NASDAQ: FBRX)prnewswire·6 hours agoFBRX+39.65%ARGX-3.20%
Argenx (ENXTBR:ARGX) Stock Faces Margin Compression As 32.3% Profitability Tests Bullish NarrativeSimplywall·Jul 24 at 04:17 PMARGX-3.20%
ARGX: Q2 revenue up 60% YoY, VYVGART expands in MG/CIDP, pipeline and financials remain strongQuartr·Jul 23 at 10:04 AMARGX-3.20%
Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·4 hours agoREGN+1.70%
ARGX: Q2 2026 delivered 60% sales growth and expanded VYVGART reach, with strong profit gainsQuartr·Jul 23 at 12:48 AMARGX-3.20%
argenx Q2 FY26 profit rises 93% to $472 million; net sales increase 60% year-over-year to $1.52 billionPUBT·Jul 23 at 12:12 AMARGX-3.20%
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business UpdateUnusual Whales·Jul 23 at 12:02 AMARGX-3.20%
argenx SE GAAP EPS of $7.32 beats by $1.12, revenue of $1.52B beats by $90Mbusinessinsider·Jul 23 at 12:26 AMARGX-3.20%
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer | MRK Stock NewsStockTitan·Jul 23 at 04:00 AMREGN+1.70%
Amgen submits data to FDA, challenges proposed Tavneos market withdrawalPUBT·Jul 24 at 07:24 AMAMGN+6.00%
argenex (NASDAQ:ARGX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarket Beat·Jul 24 at 11:18 AMARGX-3.20%
ARGX: $2.2B acquisition adds FB102, advancing autoimmune pipeline and Vision 2030 goalsQuartr·13 hours agoFBRX+39.65%ARGX-3.20%
